Gail Jones
About
Gail Jones is a scholar working on Hematology, Genetics and Molecular Biology.
According to data from OpenAlex, Gail Jones has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Gail Jones's work include Acute Myeloid Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Gail Jones is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Gail Jones collaborates with scholars based in United Kingdom, United States and Denmark. Gail Jones's co-authors include Norman L. Jones, Nigel H. Russell, Robert K. Hills, Alan K. Burnett, R. H. T. Edwards, Asim Khwaja, Steven Knapper, Jonathan Kell, David Grimwade and Graham Jackson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.
In The Last Decade
Gail Jones
30 papers receiving 1.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gail Jones United Kingdom | 18 | 750 | 545 | 281 | 275 | 238 | 32 | 1.4k | ||
| MA Goldberg United States | 14 | 868 1.2× | 390 0.7× | 155 0.6× | 333 1.2× | 78 0.3× | 24 | 1.6k | ||
| Raúl G. Carlini Venezuela | 17 | 436 0.6× | 242 0.4× | 203 0.7× | 123 0.4× | 79 0.3× | 31 | 1.4k | ||
| Oscar Ballester United States | 15 | 780 1.0× | 320 0.6× | 254 0.9× | 162 0.6× | 70 0.3× | 42 | 1.9k | ||
| Lucy Norris Ireland | 22 | 411 0.5× | 191 0.4× | 97 0.3× | 73 0.3× | 97 0.4× | 65 | 1.3k | ||
| J Aznar Spain | 21 | 898 1.2× | 152 0.3× | 418 1.5× | 193 0.7× | 63 0.3× | 81 | 1.8k | ||
| A N Békássy Sweden | 17 | 958 1.3× | 239 0.4× | 101 0.4× | 147 0.5× | 309 1.3× | 31 | 1.4k | ||
| Veena Charu United States | 18 | 605 0.8× | 284 0.5× | 236 0.8× | 103 0.4× | 22 0.1× | 45 | 1.7k | ||
| B Bizzi Italy | 20 | 877 1.2× | 143 0.3× | 144 0.5× | 388 1.4× | 82 0.3× | 97 | 1.3k | ||
| David J. Kuter United States | 20 | 926 1.2× | 211 0.4× | 205 0.7× | 260 0.9× | 16 0.1× | 50 | 1.8k | ||
| Siebold S.N. de Graaf Netherlands | 18 | 965 1.3× | 536 1.0× | 146 0.5× | 189 0.7× | 686 2.9× | 38 | 1.6k |
Countries citing papers authored by Gail Jones
Since
Specialization
Citations
This map shows the geographic impact of Gail Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Jones more than expected).
Fields of papers citing papers by Gail Jones
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Gail Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Jones. The network helps show where Gail Jones may publish in the future.
Co-authorship network of co-authors of Gail Jones
This figure shows the co-authorship network connecting the top 25 collaborators of Gail Jones. A scholar is included among the top collaborators of Gail Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail Jones. Gail Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
El‐Sharkawi, Dima, Paras Shah, Dimitrios Chanouzas, et al.. (2025). British Society for Haematology updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children with haematological malignancies: A focus on patient safety. British Journal of Haematology. 207(4). 1248–1258.
2.
Creasey, Thomas, et al.. (2022). Effective Antimicrobial Stewardship in Febrile Neutropenia: A Risk Stratification Tool Combining MASCC Score and Procalcitonin Measurements Reduces Antibiotic Duration and Length of Inpatient Stay for Haemato-Oncology Patients. Blood. 140(Supplement 1). 10788–10789.
3.
Killick, Sally, Wendy Ingram, Dominic Culligan, et al.. (2021). British Society for Haematology guidelines for the management of adult myelodysplastic syndromes. British Journal of Haematology. 194(2). 267–281.
4.
Killick, Sally, Daniel H. Wiseman, Lynn Quek, et al.. (2021). British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes. British Journal of Haematology. 194(2). 282–293.
5.
Milne, Paul, Charlotte S. Wilhelm-Benartzi, Michael R. Grunwald, et al.. (2019). Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia. Blood Advances. 3(20). 3052–3061.
6.
Freeman, Sylvie, Robert K. Hills, Paul Virgo, et al.. (2018). Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations. Journal of Clinical Oncology. 36(15). 1486–1497.
7.
Burnett, Alan K., Jamie Cavenagh, Nigel H. Russell, et al.. (2016). Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial. Haematologica. 101(6). 724–731.
8.
Burnett, Alan K., Nigel H. Russell, Robert K. Hills, et al.. (2015). Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. The Lancet Oncology. 16(13). 1295–1305.
9.
McGregor, Andrew, et al.. (2015). Incidence and outcomes for adults diagnosed with acute myeloid leukemia in the north of England: a real world study. Leukemia & lymphoma. 57(7). 1575–1584.
10.
Jones, Gail, Andrew Will, Graham Jackson, Nicholas J.A. Webb, & Simon Rule. (2015). Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. British Journal of Haematology. 169(5). 661–671.
11.
Ali, Sahra, Gail Jones, Dominic Culligan, et al.. (2015). Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. British Journal of Haematology. 170(4). 487–495.
12.
Killick, Sally, CG Carter, Dominic Culligan, et al.. (2013). Guidelines for the diagnosis and management of adult myelodysplastic syndromes. British Journal of Haematology. 164(4). 503–525.
13.
Proctor, Stephen J., Jennifer Wilkinson, Gail Jones, et al.. (2012). Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study. Blood. 119(25). 6005–6015.
14.
Jones, Gail, Nilima Parry‐Jones, Bridget S. Wilkins, Monica Else, & Daniel Catovsky. (2011). Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*. British Journal of Haematology. 156(2). 186–195.
15.
Proctor, S.J., Anne Lennard, Graham Jackson, et al.. (2009). The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control. Annals of Oncology. 21(2). 426–428.
16.
Worrillow, Lisa, A. G. Smith, Kathryn Scott, et al.. (2007). Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma. Journal of Medical Genetics. 45(3). 142–146.
17.
Jones, Gail, Penelope R. A. Taylor, Kevin Windebank, et al.. (2007). Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents. British Journal of Cancer. 97(1). 29–36.
18.
Proctor, Stephen J., et al.. (2005). An international approach to the treatment of Hodgkin's disease in the elderly: launch of the SHIELD study programme. European Journal Of Haematology. 75(s66). 63–67.
19.
Skinner, John, et al.. (1997). Post-operative feeding strategies for infants with cleft lip. International Journal of Pediatric Otorhinolaryngology. 42(2). 169–178.
20.
Jones, Gail, K. J. Killian, E. Summers, & Norman L. Jones. (1985). Inspiratory muscle forces and endurance in maximum resistive loading. Journal of Applied Physiology. 58(5). 1608–1615.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by MA Goldberg Breakdown of academic impact, for papers by Raúl G. Carlini Breakdown of academic impact, for papers by Oscar Ballester Breakdown of academic impact, for papers by Lucy Norris Breakdown of academic impact, for papers by J Aznar Breakdown of academic impact, for papers by A N Békássy Breakdown of academic impact, for papers by Veena Charu Breakdown of academic impact, for papers by B Bizzi Breakdown of academic impact, for papers by David J. Kuter Breakdown of academic impact, for papers by Siebold S.N. de Graaf